| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate |
1994-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f2bd120d342943d119b87609e4cfb88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3bd004ad5a1024be847efba32362484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_906b81e8ad515c93e8d8853c447cf3f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b2403034c52cd888cdc9111afc61f2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_654993195dff28da84e2f62893a7bdec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d77de7f8bf63fb87c8490e658062db8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b24e3bd9971dcbefa97cdb8e9e7db88c |
| publicationDate |
2001-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6251928-B1 |
| titleOfInvention |
Treatment of alzheimer's disease employing inhibitors of cathepsin D |
| abstract |
This invention provides novel benzylidene rhodanines which are useful as agents in treating or preventing conditions associated with beta-amyloid peptide. This invention further provides methods of treating or preventing Alzheimer's Disease which comprises administering to a mammal in need thereof an effective amount of one or more of the benzylidene rhodanines of the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007123-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002048746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012107153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010286041-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014086704-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11292776-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6841351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007179144-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007123-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100896237-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014127881-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015018472-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7674792-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005053936-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014015934-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004229209-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6803233-B2 |
| priorityDate |
1994-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |